This raises the interesting possibility that in cells that lack VHL and express HIF-1α, FIH-1 may favour tumour growth by decreasing the anti-proliferative consequences of HIF-1α activation and shifting the balance of HIF activation towards HIF-2α. Here, EPAS1 is linked to neoplasm.